Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
William Guyer, Chief Development Officer of Corcept Therapeutics Inc, sold 3,700 shares of common stock on August 4, 2026 for $113.12 per share.
Summary
- Option exercise/conversion: acquired 3,700 Common Stock at $21.65 ($80,105) on August 4, 2026; holds 7,685 after (Direct).
- Open-market sale: disposed of 3,700 Common Stock at $113.12 ($418,562) on August 4, 2026; holds 3,985 after (Direct).
- Option exercise/conversion: disposed of 3,700 Stock Option (right to buy) on August 4, 2026; holds 126,300 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $418,562 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
William Guyer — Officer (Chief Development Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Option exercise/conversion | Common Stock | 3,700 | $22 | $80.1K | 7,685 |
| 2026-08-04 | Open-market sale | Common Stock | 3,700 | $113 | $418.6K | 3,985 |
| 2026-08-04 | Option exercise/conversion | Stock Option (right to buy) | 3,700 | — | — | 126,300 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Option exercise/conversion (3,700 shares) |
| 2026-08-04 | Open-market sale (3,700 shares) |
| 2026-08-04 | Option exercise/conversion (3,700 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, William Guyer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.